
According to Nikkei Asia, Foxconn Technology and Japanese robotics giant Kawasaki Heavy Industries have jointly developed a humanoid nursing robot, which is currently undergoing testing at a hospital in Taiwan. The robot is expected to be officially launched in the Taiwanese market in fiscal year 2026, with a sales target of 200 units by fiscal year 2027.
Nikkei Asia reports that Kawasaki Heavy Industries, traditionally focused on industrial, automotive, and semiconductor robotics, has recently expanded into the humanoid and medical robotics sectors. The nursing robot, developed in collaboration with Foxconn, is based on Kawasaki’s own service robot, Nyokkey.
The nursing robot being tested by Foxconn and Kawasaki is equipped with built-in sensors that allow it to autonomously navigate medical facilities and avoid collisions. It features a dual-arm design capable of assisting with patient guidance and specimen transport. The two companies are currently discussing the division of responsibilities for future manufacturing, marketing, and after-sales support, with the goal of expanding the robot’s applications.
Foxconn Advances Smart Healthcare with Proprietary AI Models for Robots
In recent years, Foxconn has been actively expanding into the smart healthcare sector. During the recent NVIDIA GTC Taipei event, the company unveiled its nursing robot, Nurabot, developed by the Foxconn Research Institute. The robot integrates Foxconn’s proprietary traditional Chinese-language large language model, FoxBrain, which combines automatic speech recognition (ASR), text-to-speech synthesis (TTS), and natural language processing (NLP), and is deployed via Foxconn’s data centers.
Nurabot runs on the Isaac for Healthcare AI platform, built using three NVIDIA accelerated computing modules. This platform supports large-scale AI model training and fine-tuning on supercomputers, as well as rapid AI inference on edge devices.
In a press release issued in May, Foxconn stated that Nurabot is capable of performing repetitive tasks such as medication delivery, specimen transport, ward rounds, and patient education. The robot can reduce up to 30% of nurses’ workload and help standardize and enhance the accuracy of nursing tasks, allowing healthcare workers to focus more on patient care and clinical decision-making. Nurabot is currently undergoing live trials at Taichung Veterans General Hospital and is expected to be officially integrated into the hospital’s nursing team operations by the end of the year.
Resource: 鴻海與川崎重工合作「護理機器人」測試中,日媒:2026 年台灣上市
